- Home
- ERNA vs APT Comparison
ERNA vs APT Comparison
Compare ERNA & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERNA
- APT
- Stock Information
- Founded
- ERNA 2018
- APT 1983
- Country
- ERNA United States
- APT Canada
- Employees
- ERNA N/A
- APT N/A
- Industry
- ERNA Biotechnology: Pharmaceutical Preparations
- APT
- Sector
- ERNA Health Care
- APT
- Exchange
- ERNA Nasdaq
- APT Nasdaq
- Market Cap
- ERNA 56.4M
- APT 61.6M
- IPO Year
- ERNA N/A
- APT 1995
- Fundamental
- Price
- ERNA $0.27
- APT $5.19
- Analyst Decision
- ERNA
- APT
- Analyst Count
- ERNA 0
- APT 0
- Target Price
- ERNA N/A
- APT N/A
- AVG Volume (30 Days)
- ERNA 2.0M
- APT 32.1K
- Earning Date
- ERNA 11-12-2024
- APT 11-06-2024
- Dividend Yield
- ERNA N/A
- APT N/A
- EPS Growth
- ERNA N/A
- APT 20.88
- EPS
- ERNA N/A
- APT 0.37
- Revenue
- ERNA $598,000.00
- APT $59,288,000.00
- Revenue This Year
- ERNA N/A
- APT N/A
- Revenue Next Year
- ERNA N/A
- APT N/A
- P/E Ratio
- ERNA N/A
- APT $13.90
- Revenue Growth
- ERNA 1072.55
- APT 1.88
- 52 Week Low
- ERNA $0.26
- APT $4.64
- 52 Week High
- ERNA $2.63
- APT $6.92
- Technical
- Relative Strength Index (RSI)
- ERNA 23.35
- APT 42.27
- Support Level
- ERNA $0.26
- APT $5.06
- Resistance Level
- ERNA $0.40
- APT $5.33
- Average True Range (ATR)
- ERNA 0.06
- APT 0.22
- MACD
- ERNA 0.01
- APT 0.01
- Stochastic Oscillator
- ERNA 4.17
- APT 50.72
About ERNA Eterna Therapeutics Inc.
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply and Disposable Protective Apparel. It mainly offers a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment as well as other woven material, different styles of disposable products like shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. It also provides face masks and eye shields. It generates most of its revenues from the sale of products across the United States.